Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FAVES
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,709
Award facts
- Contract value 100% obligated
- $44,709.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $44.7K by the Defense Logistics Agency (DLA) on May 6, 2025, with an ultimate completion date of May 7, 2025. The delivery order covers Descovy 200-25 mg tablets in units of 30, with performance to be completed in Conshohocken, Pennsylvania. This award was issued without a set-aside designation, leveraging the company's competitive status as a small business in the federal pharmaceutical procurement marketplace.
This delivery order is issued under DMS Pharmaceutical Group's significant single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026. The parent IDC enables the DLA to procure a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide, encompassing branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of delivery orders for prescription medications and specialty pharmaceutical products to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FAVES?
SPE2DB25FAVES was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 6, 2025.
How much is contract SPE2DB25FAVES worth?
The government has obligated $44,709 on SPE2DB25FAVES.
Is contract SPE2DB25FAVES an order under another contract?
Yes. SPE2DB25FAVES is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVES competed?
The extent of competition for SPE2DB25FAVES was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award